<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-07-01" modified="2020-10-07" version="206">
<accession>P31939</accession>
<accession>A8K202</accession>
<accession>E9PBU3</accession>
<accession>Q13856</accession>
<accession>Q53S28</accession>
<name>PUR9_HUMAN</name>
<protein>
<recommendedName>
<fullName>Bifunctional purine biosynthesis protein ATIC</fullName>
</recommendedName>
<alternativeName>
<fullName>AICAR transformylase/inosine monophosphate cyclohydrolase</fullName>
<shortName>ATIC</shortName>
</alternativeName>
<domain>
<recommendedName>
<fullName>Phosphoribosylaminoimidazolecarboxamide formyltransferase</fullName>
<ecNumber evidence="11 12 20">2.1.2.3</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="25">5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase</fullName>
<shortName evidence="25">AICAR formyltransferase</shortName>
</alternativeName>
<alternativeName>
<fullName>AICAR transformylase</fullName>
</alternativeName>
</domain>
<domain>
<recommendedName>
<fullName evidence="22">Inosine 5'-monophosphate cyclohydrolase</fullName>
<shortName evidence="22">IMP cyclohydrolase</shortName>
<ecNumber evidence="12 15">3.5.4.10</ecNumber>
</recommendedName>
<alternativeName>
<fullName>IMP synthase</fullName>
</alternativeName>
<alternativeName>
<fullName>Inosinicase</fullName>
</alternativeName>
</domain>
<component>
<recommendedName>
<fullName>Bifunctional purine biosynthesis protein ATIC, N-terminally processed</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary" evidence="33">ATIC</name>
<name type="synonym">PURH</name>
<name type="ORF">OK/SW-cl.86</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="2225" last="2233">
<title>The human purH gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase. Cloning, sequencing, expression, purification, kinetic analysis, and domain mapping.</title>
<authorList>
<person name="Rayl E.A."/>
<person name="Moroson B.A."/>
<person name="Beardsley G.P."/>
</authorList>
<dbReference type="PubMed" id="8567683"/>
<dbReference type="DOI" id="10.1074/jbc.271.4.2225"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Hepatoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="DNA Res." volume="2" first="269" last="275">
<title>Isolation of human purH gene expressed in the rodent transformant cells by subtractive enrichment of 3'-untranslated region of human transcript.</title>
<authorList>
<person name="Yamauchi M."/>
<person name="Seki N."/>
<person name="Mita K."/>
<person name="Saito T."/>
<person name="Tsuji S."/>
<person name="Hongo E."/>
<person name="Morimyo M."/>
<person name="Shiomi T."/>
<person name="Koyama H."/>
</authorList>
<dbReference type="PubMed" id="8867801"/>
<dbReference type="DOI" id="10.1093/dnares/2.6.269"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="J. Biochem." volume="122" first="309" last="313">
<title>Characterization of molecularly cloned human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase.</title>
<authorList>
<person name="Sugita T."/>
<person name="Aya H."/>
<person name="Ueno M."/>
<person name="Ishizuka T."/>
<person name="Kawashima K."/>
</authorList>
<dbReference type="PubMed" id="9378707"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a021754"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 2-9</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF HIS-213 AND HIS-267</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2001-05" db="EMBL/GenBank/DDBJ databases">
<title>Identification of immuno-peptidmics that are recognized by tumor-reactive CTL generated from TIL of colon cancer patients.</title>
<authorList>
<person name="Shichijo S."/>
<person name="Itoh K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Colon adenocarcinoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT SER-116</scope>
<source>
<tissue>Substantia nigra</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT SER-116</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Vishwanath V."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 15-39; 91-97; 178-194; 208-225; 267-285 AND 417-426</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Cajal-Retzius cell</tissue>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1992" name="Electrophoresis" volume="13" first="960" last="969">
<title>Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes.</title>
<authorList>
<person name="Rasmussen H.H."/>
<person name="van Damme J."/>
<person name="Puype M."/>
<person name="Gesser B."/>
<person name="Celis J.E."/>
<person name="Vandekerckhove J."/>
</authorList>
<dbReference type="PubMed" id="1286667"/>
<dbReference type="DOI" id="10.1002/elps.11501301199"/>
</citation>
<scope>PROTEIN SEQUENCE OF 178-189 AND 267-281</scope>
<source>
<tissue>Keratinocyte</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Biochemistry" volume="39" first="11303" last="11311">
<title>Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis.</title>
<authorList>
<person name="Wall M."/>
<person name="Shim J.H."/>
<person name="Benkovic S.J."/>
</authorList>
<dbReference type="PubMed" id="10985775"/>
<dbReference type="DOI" id="10.1021/bi0007268"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="22168" last="22174">
<title>The kinetic mechanism of the human bifunctional enzyme ATIC (5-amino-4-imidazolecarboxamide ribonucleotide transformylase/inosine 5'-monophosphate cyclohydrolase). A surprising lack of substrate channeling.</title>
<authorList>
<person name="Bulock K.G."/>
<person name="Beardsley G.P."/>
<person name="Anderson K.S."/>
</authorList>
<dbReference type="PubMed" id="11948179"/>
<dbReference type="DOI" id="10.1074/jbc.m111964200"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>PATHWAY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Biochemistry" volume="43" first="1184" last="1192">
<title>Catalytic mechanism of the cyclohydrolase activity of human aminoimidazole carboxamide ribonucleotide formyltransferase/inosine monophosphate cyclohydrolase.</title>
<authorList>
<person name="Vergis J.M."/>
<person name="Beardsley G.P."/>
</authorList>
<dbReference type="PubMed" id="14756554"/>
<dbReference type="DOI" id="10.1021/bi035139b"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>MUTAGENESIS OF LYS-66; TYR-104; ASP-125 AND LYS-137</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1079" last="1092">
<title>The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein network.</title>
<authorList>
<person name="Boutchueng-Djidjou M."/>
<person name="Collard-Simard G."/>
<person name="Fortier S."/>
<person name="Hebert S.S."/>
<person name="Kelly I."/>
<person name="Landry C.R."/>
<person name="Faure R.L."/>
</authorList>
<dbReference type="PubMed" id="25687571"/>
<dbReference type="DOI" id="10.1074/mcp.m114.047159"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH ISNR</scope>
</reference>
<reference key="21" evidence="2">
<citation type="journal article" date="2004" name="Biochemistry" volume="43" first="1171" last="1183">
<title>Structural insights into the human and avian IMP cyclohydrolase mechanism via crystal structures with the bound XMP inhibitor.</title>
<authorList>
<person name="Wolan D.W."/>
<person name="Cheong C.-G."/>
<person name="Greasley S.E."/>
<person name="Wilson I.A."/>
</authorList>
<dbReference type="PubMed" id="14756553"/>
<dbReference type="DOI" id="10.1021/bi030162i"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH XMP</scope>
<scope>SUBUNIT</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="22" evidence="1 3">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="18034" last="18045">
<title>Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates.</title>
<authorList>
<person name="Cheong C.-G."/>
<person name="Wolan D.W."/>
<person name="Greasley S.E."/>
<person name="Horton P.A."/>
<person name="Beardsley G.P."/>
<person name="Wilson I.A."/>
</authorList>
<dbReference type="PubMed" id="14966129"/>
<dbReference type="DOI" id="10.1074/jbc.m313691200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) IN COMPLEXES WITH AICAR; XMP AND THE INHIBITORS BW1540 AND BW2315</scope>
<scope>SUBUNIT</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="23" evidence="4 5">
<citation type="journal article" date="2017" name="J. Med. Chem." volume="60" first="9599" last="9616">
<title>Discovery of LSN 3213128, a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model.</title>
<authorList>
<person name="Fales K.R."/>
<person name="Njoroge F.G."/>
<person name="Brooks H.B."/>
<person name="Thibodeaux S."/>
<person name="Torrado A."/>
<person name="Si C."/>
<person name="Toth J.L."/>
<person name="Mc Cowan J.R."/>
<person name="Roth K.D."/>
<person name="Thrasher K.J."/>
<person name="Frimpong K."/>
<person name="Lee M.R."/>
<person name="Dally R.D."/>
<person name="Shepherd T.A."/>
<person name="Durham T.B."/>
<person name="Margolis B.J."/>
<person name="Wu Z."/>
<person name="Wang Y."/>
<person name="Atwell S."/>
<person name="Wang J."/>
<person name="Hui Y.H."/>
<person name="Meier T.I."/>
<person name="Konicek S.A."/>
<person name="Geeganage S."/>
</authorList>
<dbReference type="PubMed" id="29072452"/>
<dbReference type="DOI" id="10.1021/acs.jmedchem.7b01046"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) OF 2-592 IN COMPLEXES WITH AICAR AND LSN 3213128 INHIBITOR</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Am. J. Hum. Genet." volume="74" first="1276" last="1281">
<title>AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.</title>
<authorList>
<person name="Marie S."/>
<person name="Heron B."/>
<person name="Bitoun P."/>
<person name="Timmerman T."/>
<person name="Van Den Berghe G."/>
<person name="Vincent M.-F."/>
</authorList>
<dbReference type="PubMed" id="15114530"/>
<dbReference type="DOI" id="10.1086/421475"/>
</citation>
<scope>INVOLVEMENT IN AICAR DISEASE</scope>
<scope>VARIANT AICAR ARG-426</scope>
<scope>CHARACTERIZATION OF VARIANT AICAR ARG-426</scope>
</reference>
<comment type="function">
<text evidence="11 12 15 18 20">Bifunctional enzyme that catalyzes the last two steps of purine biosynthesis (PubMed:11948179, PubMed:14756554). Acts as a transformylase that incorporates a formyl group to the AMP analog AICAR (5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide) to produce the intermediate formyl-AICAR (FAICAR) (PubMed:9378707, PubMed:11948179, PubMed:10985775). Can use both 10-formyldihydrofolate and 10-formyltetrahydrofolate as the formyl donor in this reaction (PubMed:10985775). Also catalyzes the cyclization of FAICAR to IMP (PubMed:11948179, PubMed:14756554). Is able to convert thio-AICAR to 6-mercaptopurine ribonucleotide, an inhibitor of purine biosynthesis used in the treatment of human leukemias (PubMed:10985775). Promotes insulin receptor/INSR autophosphorylation and is involved in INSR internalization (PubMed:25687571).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="11 12 20">
<text>(6S)-10-formyltetrahydrofolate + 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide = (6S)-5,6,7,8-tetrahydrofolate + 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide</text>
<dbReference type="Rhea" id="RHEA:22192"/>
<dbReference type="ChEBI" id="CHEBI:57453"/>
<dbReference type="ChEBI" id="CHEBI:57454"/>
<dbReference type="ChEBI" id="CHEBI:58467"/>
<dbReference type="ChEBI" id="CHEBI:58475"/>
<dbReference type="EC" id="2.1.2.3"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="27 28 32">
<dbReference type="Rhea" id="RHEA:22193"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="11">
<text>10-formyldihydrofolate + 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide = 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide + 7,8-dihydrofolate</text>
<dbReference type="Rhea" id="RHEA:59144"/>
<dbReference type="ChEBI" id="CHEBI:57451"/>
<dbReference type="ChEBI" id="CHEBI:57452"/>
<dbReference type="ChEBI" id="CHEBI:58467"/>
<dbReference type="ChEBI" id="CHEBI:58475"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="27">
<dbReference type="Rhea" id="RHEA:59145"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="12 15">
<text>H2O + IMP = 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide</text>
<dbReference type="Rhea" id="RHEA:18445"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:58053"/>
<dbReference type="ChEBI" id="CHEBI:58467"/>
<dbReference type="EC" id="3.5.4.10"/>
</reaction>
<physiologicalReaction direction="right-to-left" evidence="28 30">
<dbReference type="Rhea" id="RHEA:18447"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="11">
<text>10-formyldihydrofolate + 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-thiocarboxamide = 6-thio-IMP + 7,8-dihydrofolate + H2O</text>
<dbReference type="Rhea" id="RHEA:62676"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:57451"/>
<dbReference type="ChEBI" id="CHEBI:57452"/>
<dbReference type="ChEBI" id="CHEBI:145873"/>
<dbReference type="ChEBI" id="CHEBI:145875"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="27">
<dbReference type="Rhea" id="RHEA:62677"/>
</physiologicalReaction>
</comment>
<comment type="activity regulation">
<text evidence="11 19">AMP and XMP inhibit AICAR formyltransferase activity (PubMed:10985775). AICAR formyltransferase activity is inhibited by N-(6-fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5- [(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), which acts as a tumor suppression in cancer cell lines (PubMed:29072452).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="12">10 uM for 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide (with (6S)-10-formyltetrahydrofolate as cosubstrate)</KM>
<KM evidence="11">1.5 uM for 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide (with 10-formyldihydrofolate as cosubstrate)</KM>
<KM evidence="11">1.9 uM for 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide (with (6S)-10-formyltetrahydrofolate as cosubstrate)</KM>
<KM evidence="20">110 uM for (6S)-10-formyltetrahydrofolate</KM>
<KM evidence="12">100 uM for (6S)-10-formyltetrahydrofolate</KM>
<KM evidence="11">39 uM for (6S)-10-formyltetrahydrofolate</KM>
<KM evidence="11">11 uM for 10-formyldihydrofolate</KM>
<KM evidence="12">1.4 uM for 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide</KM>
<KM evidence="15">0.9 uM for 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide</KM>
<text evidence="11 12 15">kcat is 3.7 sec(-1) for AICAR formyltransferase activity with (6S)-10-formyltetrahydrofolate as substrate (PubMed:10985775). kcat is 4.1 sec(-1) for AICAR formyltransferase activity with 10-formyldihydrofolate as substrate (PubMed:10985775). kcat is 2.9 sec(-1) for AICAR formyltransferase activity with (6S)-10-formyltetrahydrofolate as substrate (PubMed:11948179). kcat is 6.0 sec(-1) for FAICAR cyclization activity (PubMed:11948179). kcat is 8.6 sec(-1) for FAICAR cyclization activity (PubMed:14756554).</text>
</kinetics>
</comment>
<comment type="pathway" evidence="12">
<text>Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1.</text>
</comment>
<comment type="pathway" evidence="12">
<text>Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1.</text>
</comment>
<comment type="subunit">
<text evidence="14 16 18">Homodimer (PubMed:14756553, PubMed:14966129). Associates with internalized INSR complexes on Golgi/endosomal membranes (PubMed:25687571). Interacts with INSR; ATIC together with PRKAA2/AMPK2 and HACD3/PTPLAD1 is proposed to be part of a signaling network regulating INSR autophosphorylation and endocytosis (PubMed:25687571).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P31939-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P31939-2</id>
<name>2</name>
<sequence type="described" ref="VSP_053495"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="20">Present in the heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas.</text>
</comment>
<comment type="domain">
<text>The IMP cyclohydrolase activity resides in the N-terminal region.</text>
</comment>
<comment type="disease" evidence="17">
<disease id="DI-00065">
<name>AICAR transformylase/IMP cyclohydrolase deficiency</name>
<acronym>AICAR</acronym>
<description>A neurologically devastating inborn error of purine biosynthesis. Patients excrete massive amounts of AICA-riboside in the urine and accumulate AICA-ribotide and its derivatives in erythrocytes and fibroblasts. AICAR causes profound mental retardation, epilepsy, dysmorphic features and congenital blindness.</description>
<dbReference type="MIM" id="608688"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text evidence="22">The de novo purine synthesis pathway includes 10 sequential steps, beginning with phosphoribosyl pyrophosphate and ending with inositol monophosphate (IMP), the first purin compound of the pathway.</text>
</comment>
<comment type="similarity">
<text evidence="26">Belongs to the PurH family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ATICID227.html"/>
</comment>
<dbReference type="EC" id="2.1.2.3" evidence="11 12 20"/>
<dbReference type="EC" id="3.5.4.10" evidence="12 15"/>
<dbReference type="EMBL" id="U37436">
<property type="protein sequence ID" value="AAA97405.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D82348">
<property type="protein sequence ID" value="BAA11559.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D89976">
<property type="protein sequence ID" value="BAA21762.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB062403">
<property type="protein sequence ID" value="BAB93490.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290067">
<property type="protein sequence ID" value="BAF82756.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC073284">
<property type="protein sequence ID" value="AAY24062.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471063">
<property type="protein sequence ID" value="EAW70529.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008879">
<property type="protein sequence ID" value="AAH08879.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2398.1">
<molecule id="P31939-1"/>
</dbReference>
<dbReference type="PIR" id="JC4642">
<property type="entry name" value="JC4642"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004035.2">
<molecule id="P31939-1"/>
<property type="nucleotide sequence ID" value="NM_004044.6"/>
</dbReference>
<dbReference type="PDB" id="1P4R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B=1-592"/>
</dbReference>
<dbReference type="PDB" id="1PKX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B/C/D=1-592"/>
</dbReference>
<dbReference type="PDB" id="1PL0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=1-592"/>
</dbReference>
<dbReference type="PDB" id="5UY8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A/B/C/D=2-592"/>
</dbReference>
<dbReference type="PDB" id="5UZ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A/B/C/D=2-592"/>
</dbReference>
<dbReference type="PDBsum" id="1P4R"/>
<dbReference type="PDBsum" id="1PKX"/>
<dbReference type="PDBsum" id="1PL0"/>
<dbReference type="PDBsum" id="5UY8"/>
<dbReference type="PDBsum" id="5UZ0"/>
<dbReference type="SMR" id="P31939"/>
<dbReference type="BioGRID" id="106961">
<property type="interactions" value="89"/>
</dbReference>
<dbReference type="IntAct" id="P31939">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000236959"/>
<dbReference type="BindingDB" id="P31939"/>
<dbReference type="ChEMBL" id="CHEMBL2518"/>
<dbReference type="DrugBank" id="DB02309">
<property type="generic name" value="5-monophosphate-9-beta-D-ribofuranosyl xanthine"/>
</dbReference>
<dbReference type="DrugBank" id="DB03442">
<property type="generic name" value="Acid yellow 54 free acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01700">
<property type="generic name" value="AICA ribonucleotide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01972">
<property type="generic name" value="Guanosine-5'-Monophosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00563">
<property type="generic name" value="Methotrexate"/>
</dbReference>
<dbReference type="DrugBank" id="DB04057">
<property type="generic name" value="N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00642">
<property type="generic name" value="Pemetrexed"/>
</dbReference>
<dbReference type="DrugBank" id="DB00116">
<property type="generic name" value="Tetrahydrofolic acid"/>
</dbReference>
<dbReference type="iPTMnet" id="P31939"/>
<dbReference type="MetOSite" id="P31939"/>
<dbReference type="PhosphoSitePlus" id="P31939"/>
<dbReference type="SwissPalm" id="P31939"/>
<dbReference type="BioMuta" id="ATIC"/>
<dbReference type="DMDM" id="23831360"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00289499"/>
<dbReference type="UCD-2DPAGE" id="P31939"/>
<dbReference type="EPD" id="P31939"/>
<dbReference type="jPOST" id="P31939"/>
<dbReference type="MassIVE" id="P31939"/>
<dbReference type="PaxDb" id="P31939"/>
<dbReference type="PeptideAtlas" id="P31939"/>
<dbReference type="PRIDE" id="P31939"/>
<dbReference type="ProteomicsDB" id="19298"/>
<dbReference type="ProteomicsDB" id="54805">
<molecule id="P31939-1"/>
</dbReference>
<dbReference type="Antibodypedia" id="4601">
<property type="antibodies" value="391 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="471"/>
<dbReference type="Ensembl" id="ENST00000236959">
<molecule id="P31939-1"/>
<property type="protein sequence ID" value="ENSP00000236959"/>
<property type="gene ID" value="ENSG00000138363"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000435675">
<molecule id="P31939-2"/>
<property type="protein sequence ID" value="ENSP00000415935"/>
<property type="gene ID" value="ENSG00000138363"/>
</dbReference>
<dbReference type="GeneID" id="471"/>
<dbReference type="KEGG" id="hsa:471"/>
<dbReference type="UCSC" id="uc002vey.5">
<molecule id="P31939-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="471"/>
<dbReference type="DisGeNET" id="471"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000138363.14"/>
<dbReference type="GeneCards" id="ATIC"/>
<dbReference type="HGNC" id="HGNC:794">
<property type="gene designation" value="ATIC"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000138363">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="ATIC"/>
<dbReference type="MIM" id="601731">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="608688">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P31939"/>
<dbReference type="OpenTargets" id="ENSG00000138363"/>
<dbReference type="Orphanet" id="250977">
<property type="disease" value="AICA-ribosiduria"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25094"/>
<dbReference type="eggNOG" id="KOG2555">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000004553"/>
<dbReference type="HOGENOM" id="CLU_016316_3_2_1"/>
<dbReference type="InParanoid" id="P31939"/>
<dbReference type="KO" id="K00602"/>
<dbReference type="OMA" id="WRVAKFV"/>
<dbReference type="PhylomeDB" id="P31939"/>
<dbReference type="TreeFam" id="TF105642"/>
<dbReference type="BioCyc" id="MetaCyc:HS06490-MONOMER"/>
<dbReference type="BRENDA" id="2.1.2.3">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="3.5.4.10">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P31939"/>
<dbReference type="Reactome" id="R-HSA-73817">
<property type="pathway name" value="Purine ribonucleoside monophosphate biosynthesis"/>
</dbReference>
<dbReference type="SABIO-RK" id="P31939"/>
<dbReference type="SIGNOR" id="P31939"/>
<dbReference type="UniPathway" id="UPA00074">
<property type="reaction ID" value="UER00133"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00074">
<property type="reaction ID" value="UER00135"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="471">
<property type="hits" value="176 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ATIC">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P31939"/>
<dbReference type="GeneWiki" id="Inosine_monophosphate_synthase"/>
<dbReference type="GenomeRNAi" id="471"/>
<dbReference type="Pharos" id="P31939">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P31939"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="P31939">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000138363">
<property type="expression patterns" value="Expressed in adrenal gland and 241 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P31939">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P31939">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003937">
<property type="term" value="F:IMP cyclohydrolase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004643">
<property type="term" value="F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006189">
<property type="term" value="P:'de novo' IMP biosynthetic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031100">
<property type="term" value="P:animal organ regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003360">
<property type="term" value="P:brainstem development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0098761">
<property type="term" value="P:cellular response to interleukin-7"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021549">
<property type="term" value="P:cerebellum development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021987">
<property type="term" value="P:cerebral cortex development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046452">
<property type="term" value="P:dihydrofolate metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006139">
<property type="term" value="P:nucleobase-containing compound metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0009116">
<property type="term" value="P:nucleoside metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009168">
<property type="term" value="P:purine ribonucleoside monophosphate biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010035">
<property type="term" value="P:response to inorganic substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046654">
<property type="term" value="P:tetrahydrofolate biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.287.440">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.140.20">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.1380">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="HAMAP" id="MF_00139">
<property type="entry name" value="PurH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR024051">
<property type="entry name" value="AICAR_Tfase_dup_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR024050">
<property type="entry name" value="AICAR_Tfase_insert_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR016193">
<property type="entry name" value="Cytidine_deaminase-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR011607">
<property type="entry name" value="MGS-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036914">
<property type="entry name" value="MGS-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR002695">
<property type="entry name" value="PurH-like"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11692">
<property type="entry name" value="PTHR11692"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01808">
<property type="entry name" value="AICARFT_IMPCHas"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02142">
<property type="entry name" value="MGS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000414">
<property type="entry name" value="AICARFT_IMPCHas"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00798">
<property type="entry name" value="AICARFT_IMPCHas"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00851">
<property type="entry name" value="MGS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52335">
<property type="entry name" value="SSF52335"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53927">
<property type="entry name" value="SSF53927"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00355">
<property type="entry name" value="purH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51855">
<property type="entry name" value="MGS"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0511">Multifunctional enzyme</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0658">Purine biosynthesis</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Bifunctional purine biosynthesis protein ATIC" id="PRO_0000192156">
<location>
<begin position="1"/>
<end position="592"/>
</location>
</feature>
<feature type="initiator methionine" description="Removed; alternate" evidence="8">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Bifunctional purine biosynthesis protein ATIC, N-terminally processed" id="PRO_0000434376" evidence="20">
<location>
<begin position="2"/>
<end position="592"/>
</location>
</feature>
<feature type="domain" description="MGS-like" evidence="10">
<location>
<begin position="2"/>
<end position="146"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="IMP" evidence="1 2 3 29 31">
<location>
<begin position="12"/>
<end position="14"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="IMP" evidence="1 2 3 29 31">
<location>
<begin position="34"/>
<end position="37"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="IMP" evidence="1 2 3 29 31">
<location>
<begin position="64"/>
<end position="67"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="IMP" evidence="1 2 3 29 31">
<location>
<begin position="101"/>
<end position="102"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="IMP" evidence="1 2 3 29 31">
<location>
<begin position="125"/>
<end position="126"/>
</location>
</feature>
<feature type="region of interest" description="IMP cyclohydrolase" evidence="9">
<location>
<begin position="2"/>
<end position="198"/>
</location>
</feature>
<feature type="region of interest" description="AICAR formyltransferase" evidence="9">
<location>
<begin position="199"/>
<end position="592"/>
</location>
</feature>
<feature type="region of interest" description="AICAR binding" evidence="1 3 16">
<location>
<begin position="207"/>
<end position="208"/>
</location>
</feature>
<feature type="region of interest" description="10-formyltetrahydrofolate binding" evidence="9">
<location>
<begin position="565"/>
<end position="566"/>
</location>
</feature>
<feature type="active site" description="Proton donor/acceptor; for FAICAR cyclization activity" evidence="29">
<location>
<position position="137"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor; for AICAR formyltransferase activity" evidence="31">
<location>
<position position="267"/>
</location>
</feature>
<feature type="binding site" description="AICAR" evidence="1 3 16 19">
<location>
<position position="267"/>
</location>
</feature>
<feature type="binding site" description="AICAR; via carbonyl oxygen" evidence="1 3 16 19">
<location>
<position position="316"/>
</location>
</feature>
<feature type="binding site" description="AICAR" evidence="1 3 16 19">
<location>
<position position="339"/>
</location>
</feature>
<feature type="binding site" description="AICAR; shared with dimeric partner" evidence="1 3 16 19">
<location>
<position position="431"/>
</location>
</feature>
<feature type="binding site" description="AICAR; shared with dimeric partner" evidence="1 3 16 19">
<location>
<position position="451"/>
</location>
</feature>
<feature type="binding site" description="10-formyltetrahydrofolate; via amide nitrogen" evidence="9">
<location>
<position position="452"/>
</location>
</feature>
<feature type="binding site" description="AICAR; via carbonyl oxygen; shared with dimeric partner" evidence="1 3 16 19">
<location>
<position position="541"/>
</location>
</feature>
<feature type="binding site" description="10-formyltetrahydrofolate" evidence="9">
<location>
<position position="546"/>
</location>
</feature>
<feature type="binding site" description="AICAR; shared with dimeric partner" evidence="1 3 16 19">
<location>
<position position="588"/>
</location>
</feature>
<feature type="site" description="Transition state stabilizer" evidence="31">
<location>
<position position="266"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="6">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="199"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_053495" evidence="23 24">
<original>MAPGQL</original>
<variation>MSSLS</variation>
<location>
<begin position="1"/>
<end position="6"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2372536." id="VAR_019306" evidence="13 21">
<original>T</original>
<variation>S</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In AICAR; loss of transformylase activity; dbSNP:rs121434478." id="VAR_019307" evidence="17">
<original>K</original>
<variation>R</variation>
<location>
<position position="426"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased affinity to FAICAR; no change in FAICAR cyclization activity." evidence="15">
<original>K</original>
<variation>A</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased FAICAR cyclization activity; no change in affinity to FAICAR." evidence="15">
<original>Y</original>
<variation>A</variation>
<variation>F</variation>
<location>
<position position="104"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased FAICAR cyclization activity; no change in affinity to FAICAR." evidence="15">
<original>D</original>
<variation>A</variation>
<variation>E</variation>
<variation>N</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased affinity to FAICAR; no change in FAICAR cyclization activity." evidence="15">
<original>K</original>
<variation>A</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased FAICAR cyclization activity; no change in affinity to FAICAR." evidence="15">
<original>K</original>
<variation>R</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of AICAR transformylase activity." evidence="20">
<original>H</original>
<variation>A</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of AICAR transformylase activity." evidence="20">
<original>H</original>
<variation>A</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA97405." ref="1" evidence="26">
<original>D</original>
<variation>G</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="6"/>
<end position="13"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="17"/>
<end position="26"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="30"/>
<end position="33"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="35"/>
<end position="42"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="43"/>
<end position="45"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="51"/>
<end position="55"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="65"/>
<end position="67"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="70"/>
<end position="77"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="82"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="96"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="106"/>
<end position="110"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="117"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="127"/>
<end position="137"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="138"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="143"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="151"/>
<end position="160"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="161"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="168"/>
<end position="197"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="217"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="222"/>
<end position="225"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="227"/>
<end position="233"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="237"/>
<end position="257"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="261"/>
<end position="266"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="269"/>
<end position="275"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="281"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="290"/>
<end position="295"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="298"/>
<end position="308"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="309"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="317"/>
<end position="323"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="327"/>
<end position="334"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="338"/>
<end position="344"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="348"/>
<end position="355"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="358"/>
<end position="360"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="363"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="375"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="384"/>
<end position="389"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="397"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="412"/>
<end position="426"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="433"/>
<end position="437"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="440"/>
<end position="445"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="451"/>
<end position="467"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="471"/>
<end position="474"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="484"/>
<end position="496"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="502"/>
<end position="509"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="512"/>
<end position="514"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="521"/>
<end position="528"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="534"/>
<end position="540"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="543"/>
<end position="545"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="546"/>
<end position="552"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="553"/>
<end position="555"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="556"/>
<end position="562"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="568"/>
<end position="577"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="581"/>
<end position="586"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1P4R"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1PKX"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1PL0"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UY8"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UZ0"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P31335"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01202"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10985775"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11948179"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14756553"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14756554"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14966129"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15114530"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25687571"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29072452"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9378707"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11948179"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8567683"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9378707"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<evidence key="27" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10985775"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11948179"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14756553"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14756554"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14966129"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9378707"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:794"/>
</source>
</evidence>
<sequence length="592" mass="64616" checksum="AD778892021F0888" modified="2002-10-10" version="3">MAPGQLALFSVSDKTGLVEFARNLTALGLNLVASGGTAKALRDAGLAVRDVSELTGFPEMLGGRVKTLHPAVHAGILARNIPEDNADMARLDFNLIRVVACNLYPFVKTVASPGVTVEEAVEQIDIGGVTLLRAAAKNHARVTVVCEPEDYVVVSTEMQSSESKDTSLETRRQLALKAFTHTAQYDEAISDYFRKQYSKGVSQMPLRYGMNPHQTPAQLYTLQPKLPITVLNGAPGFINLCDALNAWQLVKELKEALGIPAAASFKHVSPAGAAVGIPLSEDEAKVCMVYDLYKTLTPISAAYARARGADRMSSFGDFVALSDVCDVPTAKIISREVSDGIIAPGYEEEALTILSKKKNGNYCVLQMDQSYKPDENEVRTLFGLHLSQKRNNGVVDKSLFSNVVTKNKDLPESALRDLIVATIAVKYTQSNSVCYAKNGQVIGIGAGQQSRIHCTRLAGDKANYWWLRHHPQVLSMKFKTGVKRAEISNAIDQYVTGTIGEDEDLIKWKALFEEVPELLTEAEKKEWVEKLTEVSISSDAFFPFRDNVDRAKRSGVAYIAAPSGSAADKVVIEACDELGIILAHTNLRLFHH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

